We have synthesized new series of bisindole analogs (1-27), characterized by 1 HNMR and HR-EI-MS and evaluated for their anti-leishmanial potential. All compounds showed outstanding inhibitory potential with IC 50 values ranging from 0.7 ± 0.01 to 13.30 ± 0.50 µM respectively when compared with standard pentamidine with IC 50 value of 7.20 ± 0.20 µM. All analogs showed greater potential than standard except 10, 19 and 23 when compared with standard. Structure activity relationship has been also established for all compounds. Molecular docking studies were carried out to understand the binding interaction of active molecules.
Introduction
Leishmaniasis has affected almost 98 countries of the world. Every year approximately in 2 million people leishmaniasis has been reported while 350 million people are at risk [1] . The efficacy of drugs available for leishmaniasis is limited [2] . Leishmaniasis, a parasitic disease unveiled by four syndromes which are cutaneous leishmaniasis, visceral leishmaniasis, muco cutaneous leishmaniasis and kalaazar dermal leishmaniasis. In 90% population of India, Bangladesh, Nepal, East Africa and Brazil visceral leishmaniasis have been reported. The first-line drugs used for the treatment of leishmaniasis are pentavalent antimonial compounds which is not too much effective in almost 60% cases due to drug resistance. Some other treatment has been introduced for visceral leishmaniasis which has serious limitation [3] . Some second line drugs are also used for the treatment like pentamidine amphotericin B, but they have toxicity problems and unavailability [4, 5] . Some vaccine has been introduced for leishmaniasis infections which are effective with low price however effective vaccine is not yet introduce [6, 7] . The growth and survival of leishmanial parasite depend on polyamine bases which are mainly produce during metabolic process. Interaction directly with polyamine or biosynthetic pathways of these bases could result in leishmanial infection [8] . The most challenging task is the introduction of an affordable, effective and alternative antilieshmanial drug.
Bisindole compounds are known to have wide range of pharmacological activities like anticancer and antimicrobial [9] [10] [11] [12] [13] [14] , etc. Hamacanthin A bisindole alkaloid isolated from the sponge Hamacantha sp. and Spongosorites sp. exhibited effective antibacterial activity against Staphylococcus aureus and MRS with MIC of 6.45 mM and antifungal activity against Bacillus subtilis with MIC of 3.22 mM [15] [16] [17] [18] . Additionally, bisindoles compounds have been used in many biological processes such as fluorescent molecular probes [19] . Amongst several antileishmanial scaffolds reported, indole alkaloids [20] [21] [22] [23] [24] [25] showed promising activity against Leishmania parasite.
Keeping the idea for designing of new antilieshmanial drug, it is important to synthesize molecules having different biological properties based on their structure domain. We have synthesized variety of biologically active compounds for specific biological target [26] [27] [28] [29] [30] [31] .
Herein we report the synthesis of bis-indole derivatives as antilieshmanial agents.
Results and discussions

Chemistry
The synthesis of bis-indole analogs was carried out in three steps. In the first step, 2 equivalent of indole (I) was mixed with methyl-4-formylbenzoate (II) in acetic acid and reflux for 4-6 h to afford intermediate product III. The Intermediate III was then treated with hydrazine hydrate (3 mL) in ethanol, then reflux for 3-4 h to obtained intermediate IV. The intermediate IV was then mixed with different isothiocyanates to get the pure products in good yield. All reactions completion was monitored by periodic TLC. Structures of all synthesized analogs were confirmed with 1 HNMR, 13 CNMR and HR-EIMS (Scheme 1).
Biological activity
In the continuation of our effort for enzyme inhibition [32] [33] [34] [35] [36] , we have synthesized series of bisindole derivatives as a new class of anti-leishmanial agents. All compounds were screened for their leishmanial activity ( . The methyl may be involved in interaction through inductive effect. The compound 1 having 4-methoxy showed better activity than compound 2 having 3-methoxy with IC 50 value 5.30 ± 0.30 and 6.4 ± 0.20 µM respectively. The 2-nitro analog 21 (IC 50 value 3.30 ± 0.20 µM) is more potent when compared with 3-nitro analog 3 (IC 50 value 4.30 ± 0.20 µM) and 4-nitro analog 13 (IC 50 value 6.8 ± 0.20 µM). This shows that position of substituents plays a vital role in inhibition. Ortho fluoro analog 17 (IC 50 value 0.95 ± 0.05 µM) is much superior than meta and para fluoro analogs 9 and 26 with IC 50 values 1.50 ± 0.05, and 6.80 ± 0.2 µM respectively. So, it was concluded from this study that the nature, position and number of substituents play a critical role in the inhibitory potential of our designed analogs Table 1 .
Molecular docking studies of bis-indole derivatives on pteridine reductase
Docking studies with PTR shows that all the active compounds tend to adopt a similar binding mode as depicted in Fig. 1a . Comparison of the binding mode of the most active compound 8 with standard pentamidine used in the study, shows that the compound 8 interacts with the key residues of the PTR active site establishing hydrophilic and hydrophobic contacts, while in the case of the pentamidine interacts with fewer hydrophobic residues as shown in Fig. 1b . This clearly shows that this class of synthetic derivatives could be potential candidates for therapeutic against leishmaniasis.
The activity profile of these derivatives ranges from IC 50 (0.7 μM to 13.30 μM). Therefore, it's clear that these compounds are good starting point in pteridine reductase inhibitor discovery. In the following section, we limit our Fig. 2a) shows that the meta hydroxy group attached to the benzene ring forms hydrogen bonds with side chain of Gly13, Gly19 and Asn109, respectively. While the phenyl ring positioned at compound's center forms π-π stacking with Phe133. In addition, the di-indole rings form hydrophobic interaction with residues such as Met183, Leu188, Met233 and Leu226, respectively. Figure 2b shows the binding mode of compound 4, where the meta and para positioned hydroxy moieties forms hydrogen bond with side chains of Gly13, Gly19 and Asn109. Next, the phenyl ring positioned at the center of the compound forms π-π stacking with Phe11 and the di-indole rings forms hydrophobic interaction with residues such as Met183, Leu188, Met233 and Leu226 similarly as in case of compound 8. Interestingly, in the case of compound 17, the entire complex was stabilized by hydrophobic interaction. The 2-fluorobenzene group forms hydrophobic contact with Leu18 and the phenyl ring forms π-π stacking with Phe133 and hydrophobic contact with Met233, respectively. Finally, the di-indole rings form non-polar contact with Met183, Leu188 and Leu226. Likewise, the compound 9 forms hydrophobic contacts with 3-fluorobenzene group with Leu18 and the phenyl ring forms π-π stacking with Phe133 and the diindole rings interaction with Met183, Leu188, Leu226 and Tyr283 stabilize the complex.
Conclusion
It was concluded from this study that a series of bisindole analogs were synthesized, characterized by 1 HNMR and HR-EI-MS and evaluated for their anti-leishmanial potential. All compounds showed 
Materials and methods
NMR experiments were performed on Avance Bruker AM 300 MHz machine. Electron impact mass spectra (EI MS) were recorded on a Finnigan MAT-311A (Germany) mass spectrometer. Thin layer chromatography (TLC) was performed on pre-coated silica gel aluminum plates (Kieselgel 60, 254, E. Merck, Germany). Chromatograms were visualized by UV at 254 and 365 nm.
Molecular docking studies
In this recent work, we have used pteridine reductase (PTR) as vital drug target against leishmaniasis, a vital enzyme accountable for pteridine salvage in leishmania protozoans. For the molecular docking studies, we have used similar protocol that has been adopted in our previous work for both ligand preparation and docking studies of derivatives of bis-indole against PTR. Molecular docking studies were carried out using glide: a complete solution for ligand-receptor docking in small molecule drug discovery suite. Initially, receptor grid generation was done by generating grid on the Pteridine reductase structure were the grid box was centered on methotrexate (MTX) complexed ligand with 12 Å radius respectively. Both standards precision (SP) mode and extra precision (XP) mode was chosen during the Glide docking process and Glide score was considered for analysis. Further top rank scored binding mode analyzed in Pymol [37] .
General procedure for the synthesis of compounds (1-27)
The synthetic scheme towards the synthesis of bis-indole compounds involved mixing of indole with methyl-4-formylbenzoate in acetic acid to afford the ester intermediate which was then reacted with hydrazine hydrate and finally with isothiocyanate to get the final products 1-27.
The synthesis of bis-indole analogs (1-27) was carried out in three steps. In the first step, 2 equivalent of indole (I) was mixed with methyl-4-formylbenzoate (II) in acetic acid and reflux for 4-6 h. to afford intermediate product III. The Intermediate III was then treated with hydrazine hydrate (3 mL) in ethanol, then reflux for 3-4 h to obtained intermediate IV. The intermediate IV was then mixed with different isothiocyanates to get the pure products (1-27) in good yield. All reaction completion was monitored by periodic TLC. Structures of all synthesized analogs were confirmed with 1 HNMR, 13 CNMR and HR-EIMS. Di(1H-indol-3-yl)methyl)  phenyl)-N-(4-methoxyphenyl)-1,3,4-thiadiazol-2-amine (1 
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In vitro leishmaniasis assay
The assay was carried out according to Seifert and Croft [38] . Briefly, THP-1 cells (ATCC) were cultured in RPMI-1640 (R5886 Sigma) supplemented with 1% l-glutamine and 10% HIFBS (complete medium) before harvested at 1.0 × 10 6 cells/mL. Cells were diluted to 2.0 × 10 5 cells/ mL with the complete medium, seeded in 16-well Lab Tek tissue culture chamber slide (Fisher Scientific) at a seeding density of 5.0 × 10 4 macrophage/well (100 μL) and allowed to adhere by the addition of PMA (Phorbol-12 myristate Acetate P8139 Sigma) for 3 days at 37 °C in a 5% CO 2 -95% air mixture. Macrophages were then infected with long-slender (stationary stage) of Leishmania major promastigote (JISH118) obtained from The London School of Hygiene and Tropical Medicine (LSHTM) United Kingdom, which were cultured at 26 °C in Schneiders Drosophila medium (S0146 Sigma), at a macrophage-promastigote ratio of 1:5. Infected macrophages were maintained at 34 °C in a 5% CO 2 -95% air mixture. After 48 h, extracellular parasites were removed by substituting the overlay with new fresh RPMI-1640 medium supplemented with 1% l-glutamine. Fresh Pentamidine and test compounds with various concentrations were added and drug or compound activity was determined from the percentage of infected cells in drugtreated cultures in relation to non-treated cultures using GraphPad Prism after methanol fixation and Giemsa staining. All testing was triplicated.
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